REPORT ID 3995

Global Biosimilars Market Research Report 2017

Publish Date
15-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the global Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilars in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Biosimilars market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer
    Sandoz International GmbH
    Teva Pharmaceuticals Industries
    Amgen Inc
    Biocon
    Dr. Reddy?s Laboratories
    F. Hoffmann-La Roche
    Celltrion
    Samsung Bioepis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
    Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
    Peptides (Glucagon, Calcitonin)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Oncology
    Blood Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Biosimilars Market Research Report 2017
1 Biosimilars Market Overview
    1.1 Product Overview and Scope of Biosimilars
    1.2 Biosimilars Segment by Type (Product Category)
        1.2.1 Global Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Biosimilars Production Market Share by Type (Product Category) in 2016
        1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
        1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
        1.2.5 Peptides (Glucagon, Calcitonin)
    1.3 Global Biosimilars Segment by Application
        1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Blood Disorders
    1.4 Global Biosimilars Market by Region (2012-2022)
        1.4.1 Global Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Biosimilars (2012-2022)
        1.5.1 Global Biosimilars Revenue Status and Outlook (2012-2022)
        1.5.2 Global Biosimilars Capacity, Production Status and Outlook (2012-2022)

2 Global Biosimilars Market Competition by Manufacturers
    2.1 Global Biosimilars Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Biosimilars Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Biosimilars Production and Share by Manufacturers (2012-2017)
    2.2 Global Biosimilars Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Biosimilars Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Biosimilars Market Competitive Situation and Trends
        2.5.1 Biosimilars Market Concentration Rate
        2.5.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Biosimilars Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Biosimilars Capacity and Market Share by Region (2012-2017)
    3.2 Global Biosimilars Production and Market Share by Region (2012-2017)
    3.3 Global Biosimilars Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Biosimilars Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Biosimilars Consumption by Region (2012-2017)
    4.2 North America Biosimilars Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Biosimilars Production, Consumption, Export, Import (2012-2017)
    4.4 China Biosimilars Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Biosimilars Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Biosimilars Production, Consumption, Export, Import (2012-2017)
    4.7 India Biosimilars Production, Consumption, Export, Import (2012-2017)

5 Global Biosimilars Production, Revenue (Value), Price Trend by Type
    5.1 Global Biosimilars Production and Market Share by Type (2012-2017)
    5.2 Global Biosimilars Revenue and Market Share by Type (2012-2017)
    5.3 Global Biosimilars Price by Type (2012-2017)
    5.4 Global Biosimilars Production Growth by Type (2012-2017)

6 Global Biosimilars Market Analysis by Application
    6.1 Global Biosimilars Consumption and Market Share by Application (2012-2017)
    6.2 Global Biosimilars Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Biosimilars Manufacturers Profiles/Analysis
    7.1 Pfizer
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Biosimilars Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Pfizer Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Sandoz International GmbH
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Biosimilars Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Sandoz International GmbH Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Teva Pharmaceuticals Industries
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Biosimilars Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Teva Pharmaceuticals Industries Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Amgen Inc
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Biosimilars Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Amgen Inc Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Biocon
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Biosimilars Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Biocon Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Dr. Reddy?s Laboratories
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Biosimilars Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Dr. Reddy?s Laboratories Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 F. Hoffmann-La Roche
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Biosimilars Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 F. Hoffmann-La Roche Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Celltrion
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Biosimilars Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Celltrion Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Samsung Bioepis
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Biosimilars Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Samsung Bioepis Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview

8 Biosimilars Manufacturing Cost Analysis
    8.1 Biosimilars Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Biosimilars Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Biosimilars Market Forecast (2017-2022)
    12.1 Global Biosimilars Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Biosimilars Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Biosimilars Price and Trend Forecast (2017-2022)
    12.2 Global Biosimilars Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Biosimilars Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Biosimilars Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer